Myocardial ischemic events in 'real world' patients with atrial fibrillation treated with dabigatran or warfarin: A nationwide cohort study

Torben Bjerregaard Larsen; Lars Hvilsted Rasmussen; Anders Gorst-Rasmussen; Flemming Skjøth; Mary Rosenzweig; Deirdre Lane; Gregory Y H Lip

doi:10.1016/j.amjmed.2013.12.005

Myocardial ischemic events in 'real world' patients with atrial fibrillation treated with dabigatran or warfarin: A nationwide cohort study

Torben Bjerregaard Larsen, Lars Hvilsted Rasmussen, Anders Gorst-Rasmussen, Flemming Skjøth, Mary Rosenzweig, Deirdre Lane, Gregory Y H Lip

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

61 Citationer (Scopus)

Abstract

Dabigatran may provide less protection against myocardial infarction than vitamin K antagonists (VKAs) in patients with atrial fibrillation. This may be particularly evident among 'switchers' to dabigatran from VKA, as a result of discontinuation effects.

Originalsprog	Engelsk
Tidsskrift	American Journal of Medicine
Vol/bind	127
Udgave nummer	4
Sider (fra-til)	329-336
Antal sider	8
ISSN	0002-9343
DOI	https://doi.org/10.1016/j.amjmed.2013.12.005
Status	Udgivet - 2014

Adgang til dokumentet

10.1016/j.amjmed.2013.12.005

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Citationsformater

@article{aea87520cb424b2ca0114a82fac07a0c,

title = "Myocardial ischemic events in 'real world' patients with atrial fibrillation treated with dabigatran or warfarin: A nationwide cohort study",

abstract = "Dabigatran may provide less protection against myocardial infarction than vitamin K antagonists (VKAs) in patients with atrial fibrillation. This may be particularly evident among 'switchers' to dabigatran from VKA, as a result of discontinuation effects.",

author = "Larsen, {Torben Bjerregaard} and Rasmussen, {Lars Hvilsted} and Anders Gorst-Rasmussen and Flemming Skj{\o}th and Mary Rosenzweig and Deirdre Lane and Lip, {Gregory Y H}",

year = "2014",

doi = "10.1016/j.amjmed.2013.12.005",

language = "English",

volume = "127",

pages = "329--336",

journal = "American Journal of Medicine",

issn = "0002-9343",

publisher = "Elsevier",

number = "4",

}

Myocardial ischemic events in 'real world' patients with atrial fibrillation treated with dabigatran or warfarin: A nationwide cohort study. / Larsen, Torben Bjerregaard; Rasmussen, Lars Hvilsted; Gorst-Rasmussen, Anders et al.
I: American Journal of Medicine, Bind 127, Nr. 4, 2014, s. 329-336.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

TY - JOUR

T1 - Myocardial ischemic events in 'real world' patients with atrial fibrillation treated with dabigatran or warfarin

T2 - A nationwide cohort study

AU - Larsen, Torben Bjerregaard

AU - Rasmussen, Lars Hvilsted

AU - Gorst-Rasmussen, Anders

AU - Skjøth, Flemming

AU - Rosenzweig, Mary

AU - Lane, Deirdre

AU - Lip, Gregory Y H

PY - 2014

Y1 - 2014

N2 - Dabigatran may provide less protection against myocardial infarction than vitamin K antagonists (VKAs) in patients with atrial fibrillation. This may be particularly evident among 'switchers' to dabigatran from VKA, as a result of discontinuation effects.

AB - Dabigatran may provide less protection against myocardial infarction than vitamin K antagonists (VKAs) in patients with atrial fibrillation. This may be particularly evident among 'switchers' to dabigatran from VKA, as a result of discontinuation effects.

U2 - 10.1016/j.amjmed.2013.12.005

DO - 10.1016/j.amjmed.2013.12.005

M3 - Journal article

C2 - 24361757

SN - 0002-9343

VL - 127

SP - 329

EP - 336

JO - American Journal of Medicine

JF - American Journal of Medicine

IS - 4

ER -

Myocardial ischemic events in 'real world' patients with atrial fibrillation treated with dabigatran or warfarin: A nationwide cohort study

Abstract

Adgang til dokumentet

AUB Link

Fingeraftryk

Citationsformater